According to the Letter on the Identification of State-owned Companies and Enterprises, state-owned enterprises can be divided into broad sense and narrow sense. State-owned enterprises in a broad sense include pure state-owned enterprises, state-owned holding enterprises and state-owned shareholding enterprises. Therefore, Fujian Southern Pharmaceutical Co., Ltd. is a state-owned enterprise.
Fujian Nanfang Pharmaceutical Co., Ltd. is mainly engaged in the research, development, production and sales of taxanes and other anti-tumor bulk drugs and pharmaceutical intermediates. Products of Fujian Nanfang Pharmaceutical Co., Ltd.: Taxanes, other anti-tumor bulk drugs, pharmaceutical intermediates, etc.
Shareholders of Fujian Southern Pharmaceutical Co., Ltd.: Fujian Huamin Import and Export Co., Ltd., Zhang, Fujian Huaxing Venture Capital Co., Ltd., Fujian Huaxing Runming Venture Capital Co., Ltd., Wu, Gu Jiandong, Hangzhou Environmental Protection Co., Ltd., etc.
Fujian Nanfang Pharmaceutical Co., Ltd. is the largest GAP planting base of Taxus chinensis in China, the strongest production base of taxane products in China and the demonstration base of biomedical industrialization on the west side of the Taiwan Strait.